[血液造血干细胞向基因疗法的发展]
1Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health.
[Rinsho ketsueki] The Japanese journal of clinical hematology
|October 2, 2024
概括
造血干细胞 (HSC) 基因疗法为遗传性血液疾病提供终身治疗. 活体基因疗法旨在通过将基因工具直接输送到骨髓HSC来简化治疗,从而降低复杂性和成本.
科学领域:
- 生物技术是生物技术.
- 血液学 血液学 血液学
- 遗传医学是一种遗传医学.
背景情况:
- 血造干细胞 (HSC) 基因疗法显示出对遗传性血液疾病的治愈潜力.
- 高血压细胞具有自我更新和多功效,通过单一治疗可实现终身治疗.
- 使用lentiviral基因添加或编辑的自主HSC基因疗法是独立于捐赠者的.
研究的目的:
- 为了解决当前的ex vivo HSC基因疗法的复杂性和高成本.
- 在体内开发HSC基因疗法,将基因工具直接输送到骨髓HSC.
主要方法:
- 活体基因疗法包括收获,基因改造和重新注入患者的HSC.
- 活体基因疗法研究重点是将基因疗法工具直接注入骨髓.
主要成果:
- 在临床试验中,ex vivo HSC 基因治疗已经证明了有效性.
- 目前正在开发体内方法,以克服体外方法的局限性.
结论:
- 活体HSC基因疗法代表了一种有前途的策略,以简化治疗提供和降低成本.
- 将基因疗法直接输送给HSC可以扩大对遗传性血液疾病治愈疗法的准入.
相关概念视频
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Gene Therapy
25.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.3K
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
Bone Marrow Sampling and Transplants
313
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
313


